Atlas Trials

A Study to Investigate the Bioavailability and Skin Absorption of CBD and THC From GT4 Technology in Healthy Adults

Clinical trial NCT05121506 · COMPLETED

Trial details

NCT number
NCT05121506
Sponsor
Gefion Canada Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Biological AvailabilitySkin AbsorptionCBDTHC
Start date
2021-11-27
Primary completion
2022-01-18
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.